Overall, the three approved therapies manufactured by Pacira ... commitment to providing extended duration of nonopioid pain relief for acute postsurgical and chronic pain across multiple ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Alternative therapies, such as acupuncture, massage ... leading to both physical and emotional distress. In cases of acute ...

At present, the three approved therapies for neuropathic pain, and others used off-label ... endpoints in transgenic mouse models. Both acute and short-term toxicity studies required for IND ...

Alternating between cold and heat therapies provides a balanced approach, addressing both inflammation and muscle relaxation while you await further medical evaluation. Taking over-the-counter pain ...

The No Pain Act will mandate Medicare insurance coverage for non-opioid pain management, including evidence-based treatments, ...

Vertex also reported a steady increase in its R&D and SG&A expenses, reflecting its aggressive investment in pipeline ...

Acute injury, overuse (wear and tear), and underlying conditions affecting ... Some causes of arm pain require prescription medications or medical therapies and treatments to relieve pain and promote ...

The FDA granted full approval to the menin inhibitor revumenib (Revuforj) for adults and children 1 year and older with relapsed/refractory acute leukemia and a lysine methyltransferase 2A gene ( ...

in helping general practitioners rule out acute coronary syndrome in patients with chest pain. Study approach: Researchers conducted a systematic review of studies involving adult patients ...

Surprisingly, new research suggests that taking GLP-1RA is not associated with an increased risk of AKI in patients receiving anti-cancer therapies. The findings were presented at ASN Kidney Week ...